Jacob Van Dyk1, Eduardo Zubizarreta2, Yolande Lievens3. 1. Western University, London, Canada. Electronic address: vandyk@uwo.ca. 2. International Atomic Energy Agency, Vienna, Austria. 3. Radiation Oncology Department, Ghent University Hospital and Ghent University, Belgium.
Abstract
BACKGROUND: With increasing recognition of growing cancer incidence globally, efficient means of expanding radiotherapy capacity is imperative, and understanding the factors impacting human and financial needs is valuable. MATERIALS AND METHODS: A time-driven activity-based costing analysis was performed, using a base case of 2-machine departments, with defined cost inputs and operating parameters. Four income groups were analysed, ranging from low to high income. Scenario analyses included department size, operating hours, fractionation, treatment complexity, efficiency, and centralised versus decentralised care. RESULTS: The base case cost/course is US$5,368 in HICs, US$2,028 in LICs; the annual operating cost is US$4,595,000 and US$1,736,000, respectively. Economies of scale show cost/course decreasing with increasing department size, mainly related to the equipment cost and most prominent up to 3 linacs. The cost in HICs is two or three times as high as in U-MICs or LICs, respectively. Decreasing operating hours below 8h/day has a dramatic impact on the cost/course. IMRT increases the cost/course by 22%. Centralising preparatory activities has a moderate impact on the costs. CONCLUSIONS: The results indicate trends that are useful for optimising local and regional circumstances. This methodology can provide input into a uniform and accepted approach to evaluating the cost of radiotherapy.
BACKGROUND: With increasing recognition of growing cancer incidence globally, efficient means of expanding radiotherapy capacity is imperative, and understanding the factors impacting human and financial needs is valuable. MATERIALS AND METHODS: A time-driven activity-based costing analysis was performed, using a base case of 2-machine departments, with defined cost inputs and operating parameters. Four income groups were analysed, ranging from low to high income. Scenario analyses included department size, operating hours, fractionation, treatment complexity, efficiency, and centralised versus decentralised care. RESULTS: The base case cost/course is US$5,368 in HICs, US$2,028 in LICs; the annual operating cost is US$4,595,000 and US$1,736,000, respectively. Economies of scale show cost/course decreasing with increasing department size, mainly related to the equipment cost and most prominent up to 3 linacs. The cost in HICs is two or three times as high as in U-MICs or LICs, respectively. Decreasing operating hours below 8h/day has a dramatic impact on the cost/course. IMRT increases the cost/course by 22%. Centralising preparatory activities has a moderate impact on the costs. CONCLUSIONS: The results indicate trends that are useful for optimising local and regional circumstances. This methodology can provide input into a uniform and accepted approach to evaluating the cost of radiotherapy.
Authors: Danielle Rodin; Emily A Burger; Rifat Atun; Michael Barton; Mary Gospodarowicz; Surbhi Grover; Timothy P Hanna; David A Jaffray; Felicia M Knaul; Yolande Lievens; Eduardo Zubizarreta; Michael Milosevic Journal: Lancet Oncol Date: 2019-05-28 Impact factor: 41.316
Authors: Rachel E McCarroll; Beth M Beadle; Peter A Balter; Hester Burger; Carlos E Cardenas; Sameera Dalvie; David S Followill; Kelly D Kisling; Michael Mejia; Komeela Naidoo; Chris L Nelson; Christine B Peterson; Karin Vorster; Julie Wetter; Lifei Zhang; Laurence E Court; Jinzhong Yang Journal: J Glob Oncol Date: 2018-07
Authors: M E Nowee; V W J van Pelt; I Walraven; R Simões; C P Liskamp; D M J Lambregts; S Heijmink; E Schaake; U A van der Heide; T M Janssen Journal: Phys Imaging Radiat Oncol Date: 2021-07-24